Table 3 Genotype frequencies in Hong Kong Chinese patients and controls*
SNP | Control (n = 578) | SARS (n = 495) | OR (95% CI) | P |
|---|---|---|---|---|
Number (%) | ||||
Genotype | ||||
RANTES -403 | NS | |||
AA | 56 (9.7) | 54 (10.9) | ||
AG | 262 (45.3) | 223 (45.0) | ||
GG | 260 (45.0) | 218 (44.0) | ||
RANTES -28 | <0.0001 | |||
CC | 491 (84.9) | 316 (63.8) | Reference | |
CG | 73 (12.6) | 154 (31.1) | 3.28 (2.32 – 4.64) | |
GG | 14 (2.4) | 25 (5.0) | 3.06 (1.47 – 6.39) | |
RANTES ln1.1 | NS | |||
CC | 54 (9.3) | 54 (10.9) | ||
CT | 257 (44.5) | 217 (43.8) | ||
TT | 267 (46.2) | 224 (45.3) | ||
IP-10 nt1811 | NS | |||
AA | 0 (0) | 1 (0.2) | ||
AG | 29 (5.0) | 38 (7.7) | ||
GG | 549 (95.0) | 456 (92.1) | ||
IP-10 nt2867 | NS | |||
AA | 0 (0) | 1 (0.2) | ||
AC | 31 (5.4) | 38 (7.7) | ||
CC | 547 (94.6) | 456 (92.1) | ||
Mig nt367 | NS | |||
AA | 0 (0) | 1 (0.2) | ||
AG | 34 (5.9) | 38 (7.7) | ||
GG | 544 (94.1) | 456 (92.1) | ||